Company intelligence / Profile preview

LarmorBio

San Diego, California, United Stateslarmorbio.com ↗

Ownership: Private
Development stage: Other

Overview

LarmorBio is a San Diego-based biotechnology company specializing in the discovery and development of next-generation targeted protein degraders (TPDs). The company leverages a proprietary platform that integrates advanced structural biology and Nuclear Magnetic Resonance (NMR) based screening to identify novel ligands for challenging-to-drug targets. By focusing on the rational design of bifunctional molecules, LarmorBio aims to address unmet medical needs in oncology and inflammatory diseases. The company was founded by industry veterans with expertise in medicinal chemistry and structural biology, aiming to expand the reach of protein degradation beyond current limitations.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeProteolysis-targeting chimera therapy
Industry: Biotech

Beyond the preview

Go deeper on LarmorBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LarmorBio.

Explore the full profile